Literature DB >> 9421470

Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited. Metabolic studies on offspring of diabetic probands.

I Vauhkonen1, L Niskanen, E Vanninen, S Kainulainen, M Uusitupa, M Laakso.   

Abstract

No studies are available that have compared early defects in glucose metabolism in the offspring of insulin-deficient and insulin-resistant probands with non-insulin-dependent diabetes mellitus (NIDDM). To investigate this issue, we evaluated insulin secretion capacity with oral and intravenous glucose tolerance tests and with the hyperglycemic clamp, and insulin action with the euglycemic insulin clamp in 20 offspring of NIDDM patients with low fasting C-peptide (+/-450 pmol/liter), reflecting deficient insulin secretion (IS-group), 18 offspring of NIDDM patients with high fasting C-peptide (>/= 880 pmol/liter), reflecting insulin resistance (IR-group), and 14 healthy control subjects without a family history of NIDDM. The frequency of impaired glucose tolerance was 45.0% in the IS-group and 50% in the IR-group. The IS-group had lower insulin-glucose response at 30 min in the oral glucose tolerance test (85.2+/-10.0 pmol insulin per mmol glucose) than the control group (136.4+/-23.1 pmol insulin per mmol glucose; P < 0.05) and the IR-group (115.6+/-11.8 pmol insulin per mmol glucose; P = 0.05). Furthermore, the acute insulin response during the first 10 min of an intravenous glucose tolerance test was lower in the IS-group than in the IR-group. Maximal insulin secretion capacity evaluated by C-peptide levels during the hyperglycemic clamp did not differ between the groups. The IR-group had lower rates of whole body glucose uptake (60.1+/-4.6 micromol per lean body mass per minute) than did the control group (84.2+/-5.0 micromol per lean body mass per minute; P < 0.001) or the IS-group (82.6+/-5.9 micromol per lean body mass per minute; P < 0.01) and this was due to reduced glucose nonoxidation. To conclude, both impaired insulin secretion and insulin action seem to be inherited and could represent the primary defects in glucose metabolism in the offspring of NIDDM probands.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9421470      PMCID: PMC508544          DOI: 10.1172/JCI716

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  59 in total

1.  Impaired activation of glycogen synthase in people at increased risk for developing NIDDM.

Authors:  C Schalin-Jäntti; M Härkonen; L C Groop
Journal:  Diabetes       Date:  1992-05       Impact factor: 9.461

2.  Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus.

Authors:  W K Ward; D C Bolgiano; B McKnight; J B Halter; D Porte
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

3.  Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects.

Authors:  M I Uusitupa; L K Niskanen; O Siitonen; E Voutilainen; K Pyörälä
Journal:  Diabetologia       Date:  1993-11       Impact factor: 10.122

4.  Increased glucose effectiveness in normoglycemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus. A novel compensatory mechanism.

Authors:  J E Henriksen; F Alford; A Handberg; A Vaag; G M Ward; A Kalfas; H Beck-Nielsen
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

5.  Impact of obesity on insulin action in NIDDM.

Authors:  P J Campbell; M G Carlson
Journal:  Diabetes       Date:  1993-03       Impact factor: 9.461

6.  Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness.

Authors:  J M van den Ouweland; H H Lemkes; W Ruitenbeek; L A Sandkuijl; M F de Vijlder; P A Struyvenberg; J J van de Kamp; J A Maassen
Journal:  Nat Genet       Date:  1992-08       Impact factor: 38.330

7.  Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus.

Authors:  P Froguel; H Zouali; N Vionnet; G Velho; M Vaxillaire; F Sun; S Lesage; M Stoffel; J Takeda; P Passa
Journal:  N Engl J Med       Date:  1993-03-11       Impact factor: 91.245

8.  Metabolic evolution of type 2 diabetes: a 10-year follow-up from the time of diagnosis.

Authors:  L Niskanen; J Karjalainen; O Siitonen; M Uusitupa
Journal:  J Intern Med       Date:  1994-09       Impact factor: 8.989

9.  Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative.

Authors:  W Pimenta; M Korytkowski; A Mitrakou; T Jenssen; H Yki-Jarvinen; W Evron; G Dailey; J Gerich
Journal:  JAMA       Date:  1995-06-21       Impact factor: 56.272

10.  Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus.

Authors:  A Vaag; J E Henriksen; S Madsbad; N Holm; H Beck-Nielsen
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

View more
  26 in total

1.  Impact of family history of diabetes on β-cell function and insulin resistance among Chinese with normal glucose tolerance.

Authors:  Gang Chen; Meizhi Li; Yuan Xu; Nianhui Chen; Huibin Huang; Jixing Liang; Liantao Li; Junping Wen; Lixiang Lin; Jin Yao
Journal:  Diabetes Technol Ther       Date:  2012-03-09       Impact factor: 6.118

2.  Insulin clearance is different in men and women.

Authors:  Michael D Jensen; Soren Nielsen; Nidhi Gupta; Rita Basu; Robert A Rizza
Journal:  Metabolism       Date:  2011-10-13       Impact factor: 8.694

3.  Common polymorphisms of calpain-10 are associated with abdominal obesity in subjects at high risk of type 2 diabetes.

Authors:  J Pihlajamäki; U Salmenniemi; M Vänttinen; E Ruotsalainen; J Kuusisto; I Vauhkonen; S Kainulainen; M C Y Ng; N J Cox; G I Bell; M Laakso
Journal:  Diabetologia       Date:  2006-05-12       Impact factor: 10.122

Review 4.  Impaired fasting glucose as a treatment target in diabetes management.

Authors:  Rene A Oliveros; Adrienne S Zion; Yelena Rosenberg; Carrie Lynn Selvaraj; Robert Chilton
Journal:  Curr Cardiol Rep       Date:  2009-11       Impact factor: 2.931

5.  A 100-kDa urinary protein is associated with insulin resistance in offspring of type 2 diabetic patients.

Authors:  A Pätäri; P Karhapää; H Taipale; U Salmenniemi; E Ruotsalainen; P Vanninen; H Holthöfer; M Laakso
Journal:  Diabetologia       Date:  2005-07-08       Impact factor: 10.122

6.  Insulin action and secretion in healthy Hispanic-Mexican first-degree relatives of subjects with type 2 diabetes.

Authors:  F Guerrer-Romer; M Rodríguez-Morán; M González-Ortiz; E Martínez-Abundis
Journal:  J Endocrinol Invest       Date:  2001-09       Impact factor: 4.256

7.  Glucose tolerance, insulin sensitivity and insulin release in European non-diabetic carriers of a polymorphism upstream of CDKN2A and CDKN2B.

Authors:  M L Hribal; I Presta; T Procopio; M A Marini; A Stančáková; J Kuusisto; F Andreozzi; A Hammarstedt; P-A Jansson; N Grarup; T Hansen; M Walker; N Stefan; A Fritsche; H U Häring; O Pedersen; U Smith; M Laakso; G Sesti
Journal:  Diabetologia       Date:  2011-01-14       Impact factor: 10.122

8.  Twenty-four hour insulin secretion and beta cell NEFA oxidation in type 2 diabetic, morbidly obese patients before and after bariatric surgery.

Authors:  S Salinari; A Bertuzzi; A Iaconelli; M Manco; G Mingrone
Journal:  Diabetologia       Date:  2008-05-06       Impact factor: 10.122

9.  The antioxidant effect of the Malaysian Gelam honey on pancreatic hamster cells cultured under hyperglycemic conditions.

Authors:  Kalaivani Batumalaie; Rajes Qvist; Kamaruddin Mohd Yusof; Ikram Shah Ismail; Shamala Devi Sekaran
Journal:  Clin Exp Med       Date:  2013-04-13       Impact factor: 3.984

10.  Clinical Characteristics of Type 2 Diabetes Patients according to Family History of Diabetes.

Authors:  Seung Uk Jeong; Dong Gu Kang; Dae Ho Lee; Kang Woo Lee; Dong-Mee Lim; Byung Joon Kim; Keun-Yong Park; Hyoun-Jung Chin; Gwanpyo Koh
Journal:  Korean Diabetes J       Date:  2010-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.